Risk factors for pulmonary hypertension in patients with β thalassemia intermedia

European Journal of Internal Medicine

Volumn 22, Issue 6, 2011, Pages 607-610

  Karimi, Mehran ^a   Musallam, Khaled M ^b   Cappellini, Maria Domenica ^c   Daar, Shahina ^d   El Beshlawy, Amal ^e   Belhoul, Khawla ^f   Saned, Mohamed Salaheldin ^f   Temraz, Sally ^b   Koussa, Suzanne ^g   Taher, Ali T ^b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^c UNIVERSITY OF MILAN   (Italy)

^d SULTAN QABOOS UNIVERSITY   (Oman)

^e CAIRO UNIVERSITY   (Egypt)

^f Al Wasl Hospital   (United Arab Emirates)

^g Chornic Care Center   (Lebanon)

Author keywords

Hemolysis; Hypercoagulability; Pulmonary hypertension; Risk factors; Thalassemia intermedia; Thromboembolism

Indexed keywords

HYDROXYUREA;

ADULT; ARTICLE; BETA THALASSEMIA; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; ECHOCARDIOGRAPHY; ERYTHROCYTE COUNT; FEMALE; HUMAN; IRON CHELATION; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PULMONARY HYPERTENSION; RISK FACTOR; SPLENECTOMY; SYMPTOMATOLOGY; THROMBOEMBOLISM; TRANSFUSION;

ADULT; BETA-THALASSEMIA; BLOOD COAGULATION; ERYTHROCYTE COUNT; FEMALE; FERRITINS; GENOTYPE; HUMANS; HYPERTENSION, PULMONARY; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SPLENECTOMY; THROMBOEMBOLISM;

EID: 80855148205     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2011.05.013     Document Type: Article

References (45)

1. A.T. Taher, K.M. Musallam, M. Karimi, A. El-Beshlawy, K. Belhoul, and S. Daar Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study Blood 115 2010 1886 1892
2. M.D. Cappellini, K.M. Musallam, and A.T. Taher Insight onto the pathophysiology and clinical complications of thalassemia intermedia Hemoglobin 33 2009 S145 S159
3. A. Taher, H. Isma'eel, and M.D. Cappellini Thalassemia intermedia: revisited Blood Cells Mol Dis 37 2006 12 20 (Pubitemid 44062361)
4. A. Aessopos, M. Kati, and D. Farmakis Heart disease in thalassemia intermedia: a review of the underlying pathophysiology Haematologica 92 2007 658 665 (Pubitemid 350144268)
5. H. Amoozgar, N. Farhani, and M. Karimi Early echocardiographic findings in beta-thalassemia intermedia patients using standard and tissue Doppler methods Pediatr Cardiol 32 2011 154 159
6. A. Aessopos, D. Farmakis, S. Deftereos, M. Tsironi, S. Tassiopoulos, and I. Moyssakis Thalassemia heart disease: a comparative evaluation of thalassemia major and thalassemia intermedia Chest 127 2005 1523 1530 (Pubitemid 46218775)
7. A. Aessopos, D. Farmakis, M. Karagiorga, E. Voskaridou, A. Loutradi, and A. Hatziliami Cardiac involvement in thalassemia intermedia: a multicenter study Blood 97 2001 3411 3416
8. M.T. Gladwin, and E. Vichinsky Pulmonary complications of sickle cell disease N Engl J Med 359 2008 2254 2265
9. H. Isma'eel, A.H. Chafic, F.E. Rassi, A. Inati, S. Koussa, and R. Daher Relation between iron-overload indices, cardiac echo-Doppler, and biochemical markers in thalassemia intermedia Am J Cardiol 102 2008 363 367
10. G.M. Mokhtar, A.A. Adly, M.S. El Alfy, L.M. Tawfik, and A.T. Khairy N-terminal natriuretic peptide and ventilation-perfusion lung scan in sickle cell disease and thalassemia patients with pulmonary hypertension Hemoglobin 34 2010 78 94
11. H. Amoozgar, N. Farhani, and M. Karimi Risk factors for pulmonary hypertension in patients with thalassemia intermedia Eur J Haematol 85 2010 549 551
12. A. Phrommintikul, A. Sukonthasarn, R. Kanjanavanit, and W. Nawarawong Splenectomy: a strong risk factor for pulmonary hypertension in patients with thalassaemia Heart 92 2006 1467 1472 (Pubitemid 44578845)
13. S.T. Singer, F.A. Kuypers, L. Styles, E.P. Vichinsky, D. Foote, and H. Rosenfeld Pulmonary hypertension in thalassemia: association with platelet activation and hypercoagulable state Am J Hematol 81 2006 670 675 (Pubitemid 44306825)
14. A. Roghi, M.D. Cappellini, J.C. Wood, K.M. Musallam, P. Patrizia, and M.R. Fasulo Absence of cardiac siderosis despite hepatic iron overload in Italian patients with thalassemia intermedia: an MRI T2* study Ann Hematol 89 2010 585 589
15. A.T. Taher, K.M. Musallam, J.C. Wood, and M.D. Cappellini Magnetic resonance evaluation of hepatic and myocardial iron deposition in transfusion-independent thalassemia intermedia compared to regularly transfused thalassemia major patients Am J Hematol 85 2010 288 290
16. A. Aessopos, G. Stamatelos, V. Skoumas, G. Vassilopoulos, M. Mantzourani, and D. Loukopoulos Pulmonary hypertension and right heart failure in patients with beta-thalassemia intermedia Chest 107 1995 50 53
17. C. Camaschella, and M.D. Cappellini Thalassemia intermedia Haematologica 80 1995 58 68
18. R.J. Barst, M. McGoon, A. Torbicki, O. Sitbon, M.J. Krowka, and H. Olschewski Diagnosis and differential assessment of pulmonary arterial hypertension J Am Coll Cardiol 43 2004 40S 47S (Pubitemid 38759716)
19. F.X. Kleber, L. Niemoller, and W. Doering Impact of converting enzyme inhibition on progression of chronic heart failure: results of the Munich mild heart failure trial Br Heart J 67 1992 289 296
20. A. Eldor, and E.A. Rachmilewitz The hypercoagulable state in thalassemia Blood 99 2002 36 43
21. E. Shinar, E.A. Rachmilewitz, and S.E. Lux Differing erythrocyte membrane skeletal protein defects in alpha and beta thalassemia J Clin Invest 83 1989 404 410 (Pubitemid 19061158)
22. C. Hershko, G. Graham, G.W. Bates, and E.A. Rachmilewitz Non-specific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity Br J Haematol 40 1978 255 263 (Pubitemid 9040657)
23. F.A. Kuypers, and K. de Jong The role of phosphatidylserine in recognition and removal of erythrocytes Cell Mol Biol (Noisy-le-Grand) 50 2004 147 158
24. D. Tavazzi, L. Duca, G. Graziadei, A. Comino, G. Fiorelli, and M.D. Cappellini Membrane-bound iron contributes to oxidative damage of beta-thalassaemia intermedia erythrocytes Br J Haematol 112 2001 48 50 (Pubitemid 32151148)
25. V. Borenstain-Ben Yashar, Y. Barenholz, E. Hy-Am, E.A. Rachmilewitz, and A. Eldor Phosphatidylserine in the outer leaflet of red blood cells from beta-thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes Am J Hematol 44 1993 63 65 (Pubitemid 23245064)
26. D. Helley, A. Eldor, R. Girot, R. Ducrocq, M.C. Guillin, and A. Bezeaud Increased procoagulant activity of red blood cells from patients with homozygous sickle cell disease and beta-thalassemia Thromb Haemost 76 1996 322 327 (Pubitemid 26373521)
27. V. Atichartakarn, P. Angchaisuksiri, K. Aryurachai, S. Onpun, S. Chuncharunee, and A. Thakkinstian Relationship between hypercoagulable state and erythrocyte phosphatidylserine exposure in splenectomized haemoglobin E/beta-thalassaemic patients Br J Haematol 118 2002 893 898 (Pubitemid 35007399)
28. A. Taher, H. Isma'eel, G. Mehio, D. Bignamini, A. Kattamis, and E.A. Rachmilewitz Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran Thromb Haemost 96 2006 488 491 (Pubitemid 44560684)
29. A.T. Taher, K.M. Musallam, A. El-Beshlawy, M. Karimi, S. Daar, and K. Belhoul Age-related complications in treatment-naive patients with thalassaemia intermedia Br J Haematol 150 2010 486 489
30. A.T. Taher, K.M. Musallam, M. Karimi, A. El-Beshlawy, K. Belhoul, and S. Daar Splenectomy and thrombosis: the case of thalassemia intermedia J Thromb Haemost 8 2010 2152 2158
31. A.T. Taher, K.M. Musallam, W. Nasreddine, R. Hourani, A. Inati, and A. Beydoun Asymptomatic brain magnetic resonance imaging abnormalities in splenectomized adults with thalassemia intermedia J Thromb Haemost 8 2010 54 59
32. M.D. Cappellini, L. Robbiolo, B.M. Bottasso, R. Coppola, G. Fiorelli, and A.P. Mannucci Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia Br J Haematol 111 2000 467 473 (Pubitemid 32009338)
33. P.A. Zalloua, H. Shbaklo, Y.A. Mourad, S. Koussa, and A. Taher Incidence of thromboembolic events in Lebanese thalassemia intermedia patients Thromb Haemost 89 2003 767 768 (Pubitemid 36456977)
34. A. Iolascon, P. Giordano, S. Storelli, H.H. Li, B. Coppola, and A. Piga Thrombophilia in thalassemia major patients: analysis of genetic predisposing factors Haematologica 86 2001 1112 1113 (Pubitemid 33031884)
35. M.D. Cappellini, I. Motta, K.M. Musallam, and A.T. Taher Redefining thalassemia as a hypercoagulable state Ann N Y Acad Sci 1202 2010 231 236
36. D. Sonakul, P. Pacharee, T. Laohapand, S. Fucharoen, and P. Wasi Pulmonary artery obstruction in thalassaemia Southeast Asian J Trop Med Public Health 11 1980 516 523 (Pubitemid 11100714)
37. A. Sumiyoshi, K. Thakerngpol, and D. Sonakul Pulmonary microthromboemboli in thalassemic cases Southeast Asian J Trop Med Public Health 23 1992 29 31
38. V. Atichartakarn, K. Likittanasombat, S. Chuncharunee, P. Chandanamattha, S. Worapongpaiboon, and P. Angchaisuksiri Pulmonary arterial hypertension in previously splenectomized patients with beta-thalassemic disorders Int J Hematol 78 2003 139 145 (Pubitemid 37021954)
39. A. Habib, C. Kunzelmann, W. Shamseddeen, F. Zobairi, J.M. Freyssinet, and A. Taher Elevated levels of circulating procoagulant microparticles in patients with beta-thalassemia intermedia Haematologica 93 2008 941 942 (Pubitemid 351821736)
40. A. Aessopos, M. Kati, and J. Meletis Thalassemia intermedia today: should patients regularly receive transfusions? Transfusion 47 2007 792 800 (Pubitemid 46668992)
41. S. Chen, A. Eldor, G. Barshtein, S. Zhang, A. Goldfarb, and E. Rachmilewitz Enhanced aggregability of red blood cells of beta-thalassemia major patients Am J Physiol 270 1996 H1951 H1956
42. A. Taher, C. Hershko, and M.D. Cappellini Iron overload in thalassaemia intermedia: reassessment of iron chelation strategies Br J Haematol 147 2009 634 640
43. M. Karimi, M. Borzouee, A. Mehrabani, and N. Cohan Echocardiographic finding in beta-thalassemia intermedia and major: absence of pulmonary hypertension following hydroxyurea treatment in beta-thalassemia intermedia Eur J Haematol 82 2009 213 218
44. M.T. Gladwin, V. Sachdev, M.L. Jison, Y. Shizukuda, J.F. Plehn, and K. Minter Pulmonary hypertension as a risk factor for death in patients with sickle cell disease N Engl J Med 350 2004 886 895 (Pubitemid 38252536)
45. J.M. Walker, and S. Nair Detection of the cardiovascular complications of thalassemia by echocardiography Ann N Y Acad Sci 1202 2010 165 172